Trademarkia Logo

Canada

C$
TSCAN
APPROVED

on 9 Apr 2025

Last Applicant/ Owned by

TScan Therapeutics, Inc.

830 Winter StreetWaltham MA 02451

US

Serial Number

2250375 filed on 6th Mar 2023

Correspondent Address

DEETH WILLIAMS WALL LLP

150 YORK STREET, SUITE 400TORONTO

ONTARIO

CA

M5H3S5

TSCAN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders, na Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders, namely, ankylosing spondylitis, atopic dermatitis, birdshot uveitis, celiac disease, Crohn's Disease, pemphigus, psoriasis, rheumatoid arthritis, scleroderma, Sjogren's Syndrome, Systemic Lupus Erythematosus (SLE), diabetes, ulcerative colitis, vitiligo, multiple sclerosis (MS), graft vs host disease, and transplant rejection.


Classification kind code

12

Mark Details


Serial Number

2250375

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 4th Jul 2024
Search Recorded
Submitted for opposition 20
on 4th Jul 2024
Examiner's First Report
Submitted for opposition 223
on 4th Jul 2024
Total Provisional Refusal
Submitted for opposition 256
on 6th Feb 2024
Notification of Possible Opposition Sent
Submitted for opposition 135
on 21st Sept 2023
Amendment to Application
Submitted for opposition 257
on 6th Apr 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 5th Apr 2023
Created
Submitted for opposition 31
on 5th Apr 2023
Formalized
Submitted for opposition 30
on 6th Mar 2023
Filed
Submitted for opposition 228
on 6th Mar 2023
International Registration